Hodgkin's disease: Complications of therapy and excess mortality

Annals of Oncology

Volumn 8, Issue SUPPL. 1, 1997, Pages

  Hoppe, R T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiac; complications; Hodgkin's disease; mortality; secondary cancers

Indexed keywords

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; CONFERENCE PAPER; FEMALE; FOLLOW UP; HEART DISEASE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND CANCER;

EID: 0030917092     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/8.suppl_1.S115     Document Type: Conference Paper

References (16)

1. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
2. Hancock SL, Hoppe RT. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol 1996; 6: 225-42.
3. Van Leeuwen FE, Klokman WJ, Hagenbeek A et al. Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 1994; 12: 312-25.
4. Dietrich P-Y, Henry-Amar M. Cosset J-M et al. Second primary cancers in patients continuously disease-free from Hodgkin's disease: A protective role for the spleen? Blood 1994; 84:1209-15.
5. Rodriguez MA, Fuller LM, Zimmerman SO et al. Hodgkin's disease: Study of treatment intensities and incidences of second malignancies. Ann Oncol 1993; 393: 125-31.
6. Abrahamsen JF, Andersen A, Hannisdal E et al. Second malignancies after treatment of Hodgkin's disease: The influence of treatment, follow-up time, and age. J Clin Oncol 1993; 11: 255-61.
7. Swerdlow AJ, Douglas AJ, Vaughan Hudson G et al. Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: Relationships to host factors, histology, and stage of Hodgkin's disease, and splenectomy. Br J Cancer 1993; 68: 1006-11.
8. Henry-Amar M. Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's disease. Ann Oncol 1992: 3 (Suppl 4): S117-28.
9. Pinkus GS, Said JW. Hodgkin's disease, lymphocyte predominance type, nodular - a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen. Am J Pathol 1985; 118: 1 -6.
10. Birdwell SH. Hancock SL. Varghese A et al. Gastrointestinal cancer after treatment of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1996 (in press).
11. Swerdlow AJ. Douglas AJ, Hudson GV et al. Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 1992; 304(6835): 1137-43.
12. Travis LB, Curtis RE, Bennett WP et al. Lung cancer after Hodgkin's disease. J Natl Cancer Inst 1995; 87: 1324-7.
13. Van Leeuwen FD, Klokman WJ, Stovall M et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 1995: 87(20): 1530-7.
14. Hancock SL, Tucker MA, Hoppe RT. Breast cancer treatment of Hodgkin's disease. J Natl Cancer Inst 1993; 85(1): 25-31.
15. Hancock SL, Tucker MA. Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993; 270(16): 1949-55.
16. Mauch P, Kalish LA, Marcus KC et al. Long-term survival in Hodgkin's disease: Relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am 1995; 1: 33-42.